Drugs / Psyllium husk
Psyllium husk
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07610304 | Jun → Aug 2022 | hyperlipidemia | NUR International University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04534075 | Sep 2020 → Sep 2024 | anus cancer, cervical cancer, malignant colon neoplasm, ovarian cancer +2 | Sahlgrenska University Hospital | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05867550 Comparator | Jan → Mar 2023 | irritable bowel syndrome | Bahria University | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Psyllium Husk | “Altogether the fifteen capsules contains 5.5 g dietary fiber in psyllium husk.” NCT04534075 ↗ |
| Known as | Plantago seed psyllium hydrophylic mucilloid | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Known as | Psyllium 85% | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Known as | Psyllium husk, unspecified | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Known as | Psyllium hydrophilic mucilloid | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Known as | Psyllium mucilloid | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Known as | Psyllium seed coat | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108126 ↗ |
| Route | Oral | “Psyllium Husk 15-35 MG Oral Once Daily” NCT05867550 ↗ |